A single-center, prospective, open-label, pilot study of the safety, local tolerability, and efficacy of ultraviolet-C (UVC) phototherapy for the treatment of great toenail onychomycosis - 24/04/13
Andreas Boker, MD, Department of Dermatology, Brigham and Woman’s and Massachusetts General Hospitals, Harvard Medical School, Boston, MA, United States; Gabriella Rolz-Cruz, MD, Department of Dermatology, Brigham and Woman’s and Massachusetts General Hospitals, Harvard Medical School, Boston, MA, United States; Bill Cumbie, Keraderm, LLC, Hampton, VA, United States; Alexandra Kimball, MD, MPH, Brigham and Woman’s Hospital, Harvard Medical School, Boston, MA, United States
Le texte complet de cet article est disponible en PDF. 100% of the research study is sponsored by Keraderm, LLC. |
Vol 58 - N° 2S2
P. AB82 - février 2008 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?